Table 1 Classification of Leishmania spp. strains used in experiments
Leishmania Strain | Source of isolate | Country of acquisition | LRV1 status | Relative LRV1 copy number | Age | Sex | Clinical phenotype |
|---|---|---|---|---|---|---|---|
L. (V.) braziliensis (LVb−) | ATCC (MHOM/BR/75/M2903) | Brazil | LRV1− | NA | Unk | Unk | Unk |
L. (V.) braziliensis (LVb+) | Clinical | Peru | LRV1+ | 0.1 | 22 | Male | Severe |
L. (V.) guyanensis (LVg+) | ATCC (MHOM/BR/75/M4147) | Brazil | LRV1+ | Reference [1] | Unk | Unk | Unk |
L. (V.) panamensis (LVp0−) | ATCC (MHOM/PA/71/LS94) | Unknown | LRV1− | NA | Unk | Unk | Unk |
L. (V.) panamensis (LVp1−) | Clinical | Costa Rica | LRV1− | NA | 80 | Male | Severe |
L. (V.) panamensis (LVp2−) | Clinical | Costa Rica | LRV1− | NA | 17 | Male | Non-severe |
L. (V.) panamensis (LVp1+) | Clinical | Ecuador | LRV1+ | 2.17 × 10−4 | 9 | Male | Severe |
L. (V.) panamensis (LVp2+) | Clinical | Costa Rica | LRV1+ | 1.02 × 10−4 | 71 | Male | Severe |